ESC 365 - Gut leakage markers in response to strenuous exercise in patients with suspected coronary artery disease

ESC Premium Access

Gut leakage markers in response to strenuous exercise in patients with suspected coronary artery disease

Session: Risk Factors and Prevention ePosters

Topic: Exercise

Speaker: Miss S. Aune (Oslo, NO)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Miss Susanne Kristine Aune

Oslo University Hospital Ulleval, Oslo (Norway)

0 follower

224 more presentations in this session

High risk characteristics in patients with hypertrophic cardiomiyopathy for predicting cardiovascular events

Speaker: Doctor B. Keskin (Istanbul, TR)

Cardiac biomarkers as prognosticators among SARS-CoV-19 patients in a tertiary hospital in Philippines

Speaker: Doctor R. Ong (Makati, PH)

Prevalence of atherosclerosis risk factors in Egyptian patients with acute coronary syndromes; final data of the nationwide cross-sectional CardioRisk project

Speaker: Doctor A. Bendary (Benha, EG)

SF-12 Physical and Mental Health Scales predict cardiovascular events after hospitalization

Speaker: Mr R. Gascuena (Leganes, ES)

Comparison of traditional versus artificial intelligence based coronary artery disease risk prediction scores in young patients with acute coronary syndrome

Speaker: Doctor S. Vohra (Lucknow, IN)

Access the full session

Risk Factors and Prevention ePosters

Speakers: Miss S. Aune, Doctor B. Keskin, Doctor R. Ong, Doctor A. Bendary, Mr R. Gascuena...

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

Impact of changes in weight and haematocrit on the reduction in systolic office and ambulatory blood pressure with empagliflozin in patients with type 2 diabetes

27 August 2021

ESC Premium Access

SGLT-2 inhibitors in patients with and without a history of heart failure: a meta-analysis

27 August 2021

ESC Premium Access

Benefits of SGLT2-1/2 Inhibition on Heart Failure, Ischemic, and Kidney Endpoints

27 August 2021

ESC 365 is supported by